Evidence map›Paper›PMID 41225664›Full record

ArticleAdvances in rheumatology (London, England)2025

Complicated grief following pregnancy loss in women with autoimmune rheumatic diseases: a comparative cross-sectional study.

Maria Eugenia Corral-Trujillo, Rodrigo Cerda-González, Anahí Carrazco-Chapa, Rodrigo Cantu-Barreda, Luis Carlos Berlanga-Muñoz, Brayan Uriel Montes-Rodriguez, Jesus Alberto Cardenas-de la Garza, Lorena Perez-Barbosa, Cassandra Michele Skinner-Taylor, Andrea Lizbeth Guajardo-Aldaco and 2 more

Abstract readComparative Study
In one paragraph

Article in Advances in rheumatology (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Maria Eugenia Corral-TrujilloUniversity Hospital "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, (RheumatologyService), Av. Gonzalitos 235, Mitras Centro, Monterrey, 64460, N.L, Mexico.ORCID http://orcid.org/0000-0001-6906-0640
Rodrigo Cerda-GonzálezUniversity Hospital "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, (RheumatologyService), Av. Gonzalitos 235, Mitras Centro, Monterrey, 64460, N.L, Mexico.ORCID http://orcid.org/0009-0008-3715-2071
Anahí Carrazco-ChapaUniversity Hospital "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, (RheumatologyService), Av. Gonzalitos 235, Mitras Centro, Monterrey, 64460, N.L, Mexico.ORCID http://orcid.org/0000-0002-5413-021X
Rodrigo Cantu-BarredaUniversity Hospital "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, (RheumatologyService), Av. Gonzalitos 235, Mitras Centro, Monterrey, 64460, N.L, Mexico.ORCID http://orcid.org/0009-0001-6027-042X
Luis Carlos Berlanga-MuñozUniversity Hospital "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, (RheumatologyService), Av. Gonzalitos 235, Mitras Centro, Monterrey, 64460, N.L, Mexico.ORCID http://orcid.org/0009-0009-5012-5710
Brayan Uriel Montes-RodriguezUniversity Hospital "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, (RheumatologyService), Av. Gonzalitos 235, Mitras Centro, Monterrey, 64460, N.L, Mexico.ORCID http://orcid.org/0009-0008-6933-3061
Jesus Alberto Cardenas-de la GarzaUniversity Hospital "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, (RheumatologyService), Av. Gonzalitos 235, Mitras Centro, Monterrey, 64460, N.L, Mexico.ORCID http://orcid.org/0000-0002-5099-0079
Lorena Perez-BarbosaUniversity Hospital "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, (RheumatologyService), Av. Gonzalitos 235, Mitras Centro, Monterrey, 64460, N.L, Mexico.ORCID http://orcid.org/0000-0001-5033-9588
Cassandra Michele Skinner-TaylorUniversity Hospital "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, (RheumatologyService), Av. Gonzalitos 235, Mitras Centro, Monterrey, 64460, N.L, Mexico. casskinner@prodigy.net.mx.ORCID http://orcid.org/0000-0002-1800-0020
Andrea Lizbeth Guajardo-AldacoUniversity Hospital "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, (RheumatologyService), Av. Gonzalitos 235, Mitras Centro, Monterrey, 64460, N.L, Mexico.
Janett Riega-TorresUniversity Hospital "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, (RheumatologyService), Av. Gonzalitos 235, Mitras Centro, Monterrey, 64460, N.L, Mexico.ORCID http://orcid.org/0000-0003-3277-5356
Dionicio Angel Galarza-DelgadoUniversity Hospital "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, (RheumatologyService), Av. Gonzalitos 235, Mitras Centro, Monterrey, 64460, N.L, Mexico.ORCID http://orcid.org/0000-0001-9714-2109

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWomen with autoimmune rheumatic diseases (ARDs) present a higher rate of obstetric adverse events including perinatal losses (PL). The aim of this study is to determine the frequency of both complicated grief (CG) following PL and resilience in women with ARDs and compare it to a control group.

methodsWe performed an analytical, comparative, cross-sectional study from November 2022 to July 2024. Women with and without an ARD diagnosis with a history of PL who completed a self-report survey including the Perinatal Grief Scale (PGS) and the Wagnild and Young Resilience Scale (RS) were selected. We analyzed sociodemographic data, clinical characteristics, and scale scores with SPSS Version 25.

resultsNinety participants were enrolled in this study. Thirty-three women met criteria for CG following PL, 22 (66.7%) belonged to the control group and 11 (33.3%) to the ARD group (p = 0.016). The RS median score was 138.00 (IQR 117–163). A logistic regression revealed that having an ARD is independently associated with not presenting CG (OR = 0.338; p = 0.018, 95% CI = 0.138–0.829), suggesting that women with ARDs are 2.95 times less likely to develop CG.

conclusionsWomen with ARDs had a lower frequency of CG following PL than the control group. We found no significant difference between groups regarding resilience capacity. The logistic regression suggests that ARDs serve as a protective factor for developing CG following PL. Screening for CG following PL in women with and without ARDs may help optimize maternal and infant health. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

Abortion, SpontaneousAutoimmune DiseasesGriefRheumatic DiseasesAdultCross-Sectional StudiesFemaleHumansPregnancyResilience, PsychologicalGriefObstetric outcomesPerinatal deathsReproductive healthRheumatic diseases

Identifiers

PMID41225664
PMCPMC13488759

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.